Placeholder Banner

Biodefense: 2010 National Security Strategy

March 10, 2016

Time and again in our Nation's history, Americans have risen to meet -and to shape- moments of transition. This must be one of those moments. We live in a time of sweeping change. The success of free nations, open markets and social progress in recent decades have accelerated globalization on an unprecedented scale. This has opened the doors of opportunity around the globe, extended democracy to hundreds of millions of people and made peace possible among the major powers. Yet globalization has also intensified the dangers we face - from international terriorism and the spread of deadly technologies, to economic upheaveal and a changing climate.

Download Full Comments Below
National Security Strategy
Read the strategy
Discover More
On November 9, BIO submitted comments on the FDA Draft Guidance, Drug-Drug Interaction Assessment for Therapeutic Proteins. In the comments, BIO thanks the FDA for the opportunity to submit comments but requests that the Guidance include a…
On August 6, BIO submitted comments on the NMPA Draft Technical Guideline on Clinical Trials of Cellular Immunotherapy Products. In the comments, BIO thanks NMPA for the opportunity to submit comments but argues for a more robust commenting period…
October 30, 2020 Re: Docket No. FDA–2020-D-1564: FDA Draft Guidance, Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation. Dear Sir/Madam: The Biotechnology…